Universal

UVVNYSEUSD

THESIS ALERT

Email me when the UVV thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$37.95
−$0.64 (−1.66%)Today 1M −9.64%
After hours$37.87−0.22%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$38.59
Prior regular-session close from the quote source.
$37.65–$38.48
Regular-session low and high so far today.
473.1K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 8 projected
Projected for 2027-02-08 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$37.38–$59.38
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own UVV if Universal turns global farmer contracts, scale processing and seasonal financing into a cash-generating bridge business: tobacco provides stable volume and customer relationships while management tries to grow higher‑margin plant‑based Ingredients to offset tobacco cyclicality.

UVV price history

Latest price$37.95Today−$0.64 (-1.66%)
UVV -9.13%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Universal's global farmer contracts, origin presence and processing services will keep consolidated revenue relatively resilient despite pressure in end‑market cigarette volumes because farmers and manufacturers rely on its scale and service.HoldingMateriality: High

    Item 1. Business: Universal is described as "the leading global leaf tobacco supplier" with operations in over 30 countries and long‑standing farmer contracts. If true, revenue remains a stable base that supports dividends and financing; if false, top-line erosion will force cuts to returns or strategic retrenchment.

    Watch: A sustained secular decline in combustible tobacco demand or regulatory bans (flavor/menthol or broader restrictions) in large markets that reduce manufacturer purchases.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Item 1. Business: Universal is described as "the leading global leaf tobacco supplier" with operations in over 30 countries and.

    Open source ↗
  • Growth and disciplined M&A/investment in Ingredients can materially raise consolidated margins and cash flow, because Ingredients is higher value‑added and less seasonal than Tobacco.HoldingMateriality: High

    Item 1. Business: strategy explicitly prioritizes growing the Ingredients Operations "organically and through disciplined acquisitions" to provide value‑added product offerings. If Ingredients scales profitably, it can offset tobacco cyclicality and justify a higher valuation multiple; failure leaves the company exposed to tobacco's margin pressure.

    Watch: Failure to secure CPG customers or to integrate acquisitions profitably, leaving Ingredients as a cost center rather than a margin driver.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Item 1. Business: strategy explicitly prioritizes growing the Ingredients Operations "organically and through disciplined acquisitions" to provide value‑added product offerings.

    Open source ↗
  • Seasonal tobacco crop financing and inventory timing will continue to produce volatile operating cash flow (peaks in Q1/Q2), so cash generation will remain lumpy unless working capital patterns change.StrengtheningMateriality: Medium

    MD&A: the company states peak working capital requirements are reached in the first and second fiscal quarters and seasonal borrowing can increase by up to $400 million. Lumpy cash flow requires large committed credit lines and limits discretionary capital returns; smoothing cash flow materially raises free cash available for buybacks or M&A.

    Watch: Management successfully reduces uncommitted tobacco inventory to target (<20% of tobacco inventory) and tightens receivables/factoring, materially lowering working capital needs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    MD&A: the company states peak working capital requirements are reached in the first and second fiscal quarters and seasonal borrowing.

    Open source ↗
  • Ongoing dividends and share repurchases are sustainable only if operating cash flow normalizes; capital returns will be the first lever management uses but are constrained by working capital needs.HoldingMateriality: Medium

    MD&A: the company returned $81.3 million in dividends in FY2026 and has a board‑approved $100 million repurchase authorization (no repurchases in FY2026). Shareholder returns (dividend + potential buybacks) support the equity case; if cash flow weakens, returns will be reduced, pressuring the stock.

    Watch: Material non‑operational cash inflows (asset sales) that temporarily fund returns without improving operations.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    MD&A: the company returned $81.3 million in dividends in FY2026 and has a board‑approved $100 million repurchase authorization (no repurchases.

    Open source ↗
  • Consolidated operating margins will only recover if either tobacco pricing/volume stabilizes at historical levels or Ingredients achieves structural, higher margins; a persistent decline in operating income relative to revenue signals structural demand loss in Tobacco that management cannot offset.WeakeningMateriality: Medium

    operating_income (annual) fell from 232.80M (FY2025) to 168.45M (FY2026) while revenue was roughly unchanged, indicating margin compression. Operating margin trajectory determines free cash flow and the sustainability of capital returns; a structural margin collapse would materially impair equity value.

    Watch: Large regulatory or demand shocks reducing global leaf tobacco manufacturer purchases (e.g., extensive flavor bans, accelerated shift to non‑leaf nicotine solutions).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    operating_income (annual) fell from 232.80M (FY2025) to 168.45M (FY2026) while revenue was roughly unchanged, indicating margin compression.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Universal's global farmer contracts, origin presence and processing services will keep consolidated revenue relatively resilient despite pressure in end‑market cigarette volumes because farmers and manufacturers rely on its scale and service. If true, revenue remains a stable base that supports dividends and financing; if false, top-line erosion will force cuts to returns or strategic retrenchment.

Growth and disciplined M&A/investment in Ingredients can materially raise consolidated margins and cash flow, because Ingredients is higher value‑added and less seasonal than Tobacco. If Ingredients scales profitably, it can offset tobacco cyclicality and justify a higher valuation multiple; failure leaves the company exposed to tobacco's margin pressure.

Seasonal tobacco crop financing and inventory timing will continue to produce volatile operating cash flow (peaks in Q1/Q2), so cash generation will remain lumpy unless working capital patterns change. Lumpy cash flow requires large committed credit lines and limits discretionary capital returns; smoothing cash flow materially raises free cash available for buybacks or M&A.

Ongoing dividends and share repurchases are sustainable only if operating cash flow normalizes; capital returns will be the first lever management uses but are constrained by working capital needs. Shareholder returns (dividend + potential buybacks) support the equity case; if cash flow weakens, returns will be reduced, pressuring the stock.

Consolidated operating margins will only recover if either tobacco pricing/volume stabilizes at historical levels or Ingredients achieves structural, higher margins; a persistent decline in operating income relative to revenue signals structural demand loss in Tobacco that management cannot offset. Operating margin trajectory determines free cash flow and the sustainability of capital returns; a structural margin collapse would materially impair equity value.

All standing thesis claims
Original report summary

Universal turns global farmer contracts, scale processing and seasonal financing into a cash-generating bridge business: tobacco provides stable volume and customer relationships while management tries to grow higher‑margin plant‑based Ingredients to offset tobacco cyclicality.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Universal

Where the evidence on Universal disagrees: Mixed on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 1 strengthening, 3 holding and 1 weakening.

Bull case: what the evidence supports

  • Universal's global farmer contracts, origin presence and processing services will keep consolidated revenue relatively resilient despite pressure in end‑market cigarette volumes because farmers and manufacturers rely on its scale and service.

    sec.gov ↗

  • Growth and disciplined M&A/investment in Ingredients can materially raise consolidated margins and cash flow, because Ingredients is higher value‑added and less seasonal than Tobacco.

    sec.gov ↗

  • Seasonal tobacco crop financing and inventory timing will continue to produce volatile operating cash flow (peaks in Q1/Q2), so cash generation will remain lumpy unless working capital patterns change.

    sec.gov ↗

  • Ongoing dividends and share repurchases are sustainable only if operating cash flow normalizes; capital returns will be the first lever management uses but are constrained by working capital needs.

    sec.gov ↗

Bear case: what the evidence questions

  • Consolidated operating margins will only recover if either tobacco pricing/volume stabilizes at historical levels or Ingredients achieves structural, higher margins; a persistent decline in operating income relative to revenue signals structural demand loss in Tobacco that management cannot offset.

    sec.gov ↗

Thesis-Break Engine

What has broken in Universal’s thesis

Each break OptimistFi flagged on Universal, dated — with what has historically followed the same kind of break across the market, not a forecast for Universal.

peers+15%-20%-2%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -2% path vs comparable companies over six months, inside the middle-half range (+15% to -20%). A base rate, not a forecast.
  • CEO / officer changecondition set before this filing

    Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Director or principal officer change.

    Universal filed an SEC 8-K on 2026-11-04: Director or principal officer change. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Universal filed an SEC 8-K on 2026-11-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Entered a material definitive agreement.

    Universal filed an SEC 8-K on 2026-10-13: Entered a material definitive agreement. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A sustained secular decline in combustible tobacco demand or regulatory bans (flavor/menthol or broader restrictions) in large markets that reduce manufacturer purchases.
  • Failure to secure CPG customers or to integrate acquisitions profitably, leaving Ingredients as a cost center rather than a margin driver.
  • Management successfully reduces uncommitted tobacco inventory to target (<20% of tobacco inventory) and tightens receivables/factoring, materially lowering working capital needs.
  • Material non‑operational cash inflows (asset sales) that temporarily fund returns without improving operations.
  • Large regulatory or demand shocks reducing global leaf tobacco manufacturer purchases (e.g., extensive flavor bans, accelerated shift to non‑leaf nicotine solutions).

UVV news

Loading headlines…

Financial statements

UVV income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

UVV: quick answers

When does Universal (UVV) report earnings next?
Universal's next results are projected for February 8, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 4, 2026. Earnings calendar
What is UVV's short interest?
As of October 30, 2026, 2.1M UVV shares were sold short, 8.57% of its shares outstanding, down 4.1% from the count before. At the stock's average daily volume that is 5.5 days to cover. FINRA publishes the count twice a month. UVV short interest history
Have members of Congress traded UVV?
Reports made public in the last 90 days disclose 2 trades in UVV by 1 filer: 1 purchase and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed UVV trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.